![]() Samumed Samumed is a pharmaceutical platform company focused on advancing regenerative medicine and oncology applications through research and innovation. | ![]() AdAlta AdAlta is a drug discovery and development company intended to generate a new class of protein therapeutics, known as i-bodies. | ![]() BioMarin Pharmaceutical BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions. | |
Founding Date | Founding Date 2008 | Founding Date 2006 | Founding Date 1997 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations San Diego, US HQ San Diego, US | Locations Bundoora, AU HQ Melbourne, AU | Locations San Rafael, US HQ Martínez, AR Crows Nest, AU Sao Paulo, BR Bogotá, CO Kronberg Im Taunus, DE Wanchai, HK see more |
Employees | Employees 1701% increase | Employees 9 | Employees 3,0015% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 7.2 m | Valuation ($) 13.3 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $3.2b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $717.4m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $677k (FY, 2025) | Gross profit $2.5b (FY, 2025) |
Net income | Net income N/A | Net income ($4.5m) (FY, 2025) | Net income $348.9m (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 438m | Total funding raised $ 3m | Total funding raised N/A |

AdAlta is a drug discovery and development company intended to generate a new class of protein therapeutics, known as i-bodies.
View company
BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions.
View company